Dr. Lingbing Zhang

Akexis is a biotechnology company dedicated to developing transformative cancer therapeutics. Led by a team of seasoned scientists, clinicians, and innovators, Akexis is committed to advancing solutions that address the highly unmet needs of late-stage cancer patients. Our vision is to revolutionize late-stage cancer by pushing boundaries and transforming it from a terminal disease to a manageable and curable condition. Through innovative approaches and tailored treatments, we aim to empower patients with new possibilities for long-term remission and improved quality of life.